BMS-1001 is a novel and potent small molecule inhibitor of the PD-1/PD-L1 protein protein interaction with IC50 value of 2.25 nM in cell free assays.

PROTAC PD-1/PD-L1 degrader-1 is a novel First-in-class PD-L1 degrader based on PROTAC technology.

Atazanavir (also called Latazanavir, Zrivada, Reyataz, BMS-232632) is an azapeptide and HIV-protease inhibitor that is used in the treatment of HIV infections and AIDS in combination with other anti-HIV agents.

Sulfosuccinimidyl oleate (SSO) is a long chain fatty acid acting as an irreversible inhibitor of the fatty acid translocase CD36 with anti-inflammatory effects.